Basic Information
ID: ALA836560
Type: Functional
Description: Concentration required to inhibit plaque formation in human cytomegalovirus cultures was determined
Format: BAO_0000218
Organism: Human betaherpesvirus 5
Target: Human betaherpesvirus 5(ALA371)
Document: ALA1138812
Concentration required to inhibit plaque formation in human cytomegalovirus cultures was determined: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA836560
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 436.88 | 0.78 | 0.78 |
| 245.49 | 1.81 | 1.81 |
| 289.94 | 1.92 | 1.92 |
| 378.85 | 2.14 | 2.14 |
| 347.98 | 0.56 | 0.56 |
| 171.41 | 2.37 | 2.37 |
| 215.87 | 2.48 | 2.48 |
| 304.77 | 2.70 | 2.70 |
| 275.52 | 1.17 | 1.17 |
| 319.97 | 1.28 | 1.28 |
| 408.87 | 1.50 | 1.50 |
| 255.23 | -1.97 | -1.97 |
| 353.59 | 1.61 | 1.61 |
| 398.04 | 1.72 | 1.72 |
| 404.64 | 2.16 | 2.16 |
| 404.64 | 2.16 | 2.16 |
| 403.65 | 2.76 | 2.76 |
| 357.99 | 0.02 | 0.02 |
| 269.08 | -0.20 | -0.20 |
| 347.98 | 0.56 | 0.56 |
| 436.88 | 0.78 | 0.78 |
| 303.53 | 0.45 | 0.45 |
| 303.53 | 0.45 | 0.45 |
| 347.98 | 0.56 | 0.56 |
| 436.88 | 0.78 | 0.78 |
| 319.14 | 0.95 | 0.95 |